We are live on ! Find out more
MET.PRA icon

MetLife Series A Preferred Stock

4 hedge funds and large institutions have $3.12M invested in MetLife Series A Preferred Stock in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more capital inflows, than outflows

Capital inflows: $90.7K | Capital outflows: $27.8K

0.01% more ownership

Funds ownership: 0.55% → 0.56% (+0.01%)

33% less funds holding

Funds holding: 6 → 4 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MET.PRA Hedge Fund Activity: Q2 2020 in Review

4 of the 4,891 institutional investors tracked by Wall St. Rank reported a position in MetLife Series A Preferred Stock (MET.PRA) for Q2 2020, worth a combined $3.12M — up 6.2% from $2.93M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MET.PRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was PNC Financial Services Group, adding an estimated $45.6K. The largest seller was Glenmede Trust, exiting entirely with an estimated $19K sold.

  • 4 institutional investors held MetLife Series A Preferred Stock (MET.PRA) as of Q2 2020, down from 6 in Q1 2020.
  • Funds reported $3.12M of MetLife Series A Preferred Stock stock for Q2 2020, up 6.2% quarter-over-quarter.
  • 0 funds opened new MetLife Series A Preferred Stock positions in Q2 2020 and 2 closed out, a net change of -2 holders.
  • The largest MetLife Series A Preferred Stock buyer in Q2 2020 was PNC Financial Services Group, an estimated $45.6K added.
  • The largest MetLife Series A Preferred Stock seller in Q2 2020 was Glenmede Trust, an estimated $19K sold.

Based on aggregated 13F filings for Q2 2020.